Literature DB >> 7578379

Oral complications of local and systemic cancer treatment.

W Carl1.   

Abstract

Acute and chronic complications of oral tissues and changes in physiologic process frequently accompany cancer therapies. Mucositis is a common dose-limiting complication in patients receiving systemic cancer chemotherapy, bone marrow transplantation, and local irradiation for tumors in the head and neck area. In addition, mucosal ulcerations may become portals for the invasion of pathogens that in turn may be life threatening. Oral environment changes and salivary gland dysfunction cause an increase in dental caries and periodontal disease in dentulous patients who receive radiation therapy in and around the oral cavity. Some of these therapy-related oral complications can be controlled by pretherapy modification of the oral environment, such as elimination of acute and potential dental and periodontal foci of pathoses, patient participation in oral care, and awareness by dentists and oncologists that cancer patients require specific oral care. Prevention and management of oral mucositis, as well as prevention and control of dental pathoses, are still problems that need further investigation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578379     DOI: 10.1097/00001622-199507000-00005

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  7 in total

Review 1.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

2.  IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.

Authors:  D A Mosca; M A Hurst; W So; B S Viajar; C A Fujii; T J Falla
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers.

Authors:  Gerry J Barker; Joel B Epstein; Karen B Williams; Meir Gorsky; Judith E Raber-Durlacher
Journal:  Support Care Cancer       Date:  2004-11-12       Impact factor: 3.603

4.  Assessing the topical application efficiency of two biological agents in managing chemotherapy-induced oral mucositis in children: A randomized clinical trial.

Authors:  Muaaz Alkhouli; Mohannad Laflouf; John C Comisi
Journal:  J Oral Biol Craniofac Res       Date:  2021-04-12

5.  Cancer Therapy: A Continuance of Health Burden.

Authors:  Sowmya Kasetty; Samar Khan; Sudheendra U Shridhar; Sandeep Gupta; Manisha Tijare; Shreenivas Kallianpur; T Raju Ragavendra
Journal:  World J Oncol       Date:  2012-10-28

6.  Oral mucositis in children suffering from acute lymphoblastic leukaemia.

Authors:  Elżbieta Pels
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

7.  Protective effects of polysaccharides and polyhydric alcohols in a dry mouth model in cultured cells.

Authors:  Akiko Morito; Koichi Fujisawa; Toru Eguchi; Yojiro Ota
Journal:  Support Care Cancer       Date:  2011-04-09       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.